These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17763164)

  • 1. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
    Kang SW; Kim YW; Kim YH; Sohn HS; Joo H; Kim E
    Ren Fail; 2007; 29(6):693-8. PubMed ID: 17763164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis.
    de Souza CM; Braosi AP; Luczyszyn SM; Avila AR; de Brito RB; Ignácio SA; Probst CM; Riella MC; Sotomaior VS; Mira MT; Pecoits-Filho R; Trevilatto PC
    Blood Purif; 2007; 25(5-6):411-9. PubMed ID: 17914260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
    Wu HC; Ling H; Na SP; Xie RJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2076-80. PubMed ID: 16313808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Manchanda PK; Kumar A; Kaul A; Mittal RD
    Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.
    Bellini MH; Figueira MN; Piccoli MF; Marumo JT; Cendoroglo MS; Neto MC; Dalboni MA; Batista MC; Goes MA; Schor N
    Nephrology (Carlton); 2007 Jun; 12(3):289-93. PubMed ID: 17498125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
    Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
    Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
    Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
    Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL; Shih MC; Humphries DE; Guarino PD; Kaufman JS; Goldfarb DS; Warren SR; Gaziano JM; Lavori P;
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis.
    Baioni CS; de Souza CM; Ribeiro Braosi AP; Luczyszyn SM; Dias da Silva MA; Ignácio SA; Naval Machado MA; Benato Martins WD; Riella MC; Pecoits-Filho R; Trevilatto PC
    J Periodontal Res; 2008 Oct; 43(5):578-84. PubMed ID: 18624938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
    Buraczynska M; Ksiazek P; Kubit P; Zaluska W
    Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.
    Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A
    Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
    Norata GD; Ongari M; Garlaschelli K; Tibolla G; Grigore L; Raselli S; Vettoretti S; Baragetti I; Noto D; Cefalù AB; Buccianti G; Averna M; Catapano AL
    J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy.
    Pirhan D; Atilla G; Emingil G; Tervahartiala T; Sorsa T; Berdeli A
    J Clin Periodontol; 2009 Jun; 36(6):474-81. PubMed ID: 19453573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.